Abstract
Each year 600,000 individuals are diagnosed with head and neck squamous cell carcinoma (HNSCC), which is the eight most common type of cancer worldwide, with an overall 5-year survival rate below 50%, and in cases diagnosed in advanced stages the survival rate is as low as 20%. Treatment of HNSCC had no significant progress in the past 4 decades, and the surgical resection with/without ra…